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Pelvic tumours are difficult to treat, with large size at presentation, close 
proximity of viscera and neurovascular structures and a lack of neoadjuvant 
therapy. Short-term outcomes using navigated surgery reduced surgical time, 
blood loss, intralesional resection rate and preserved function.  
Aims
We investigated the local recurrence rate at extended follow-up in patients 
following navigated resection of primary pelvic and sacral tumours. 
Methods
This prospective cohort study comprised 23 consecutive patients between 2010 
and 2012 undergoing primary pelvic and sacral tumour resection using 
computer navigation. Local recurrence (LR) and mortality rates were calculated 
using the Kaplan-Meier method.
Results
Bone resection margins were all clear, with no bony recurrence. At a median 
follow-up of 6.0 years, eight patients (34.8%) developed soft-tissue LR with an 
overall cumulative LR rate at 6-years of 35.1% (95% CI=19.3-58.1%). Overall 
cumulative all-cause mortality rate at 6-years was 26.1% (95% CI = 12.7%-
49.1%).
Conclusion
Despite the positive early experience with computer navigation-assisted resection 
LR rates remain high. With increasing knowledge of the size of soft tissue margins 
required to reduce LR and the close proximity of native structures in the pelvis, 
we advise against compromising resection to preserve function and encourage 
surgeons to reduce LR by prioritising wide tumour resection margins. Computer 
navigation remains a useful tool to aid pelvic tumour resection, but adequate soft 
tissue margins remain essential.
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The oncological outcomes of patients with primary tumours located in the pelvis 
or sacrum are worse than tumours originating at the extremities (31% vs. 51% 
10-year overall patient survival)1.  In the pelvis, tumour size is larger at 
presentation and the close proximity of visceral and neurovascular structures 
makes it difficult to achieve adequate surgical clearance2,3. Half of patients 
experience surgical complications2. Furthermore, we lack neo-adjunctive 
chemoradiotherapy to downstage tumours or treat marginal resections in 
chondrosarcoma and chordoma, which are the predominant tumour histiotypes 
in the pelvis. Han et al, 2010 reported a mean 5-year recurrence-free survival 
rate of 45% for primary pelvic sarcomas2, with local recurrence rates for sacral 
chordoma reported to be as high as 65% at 5-years4. Chondrosarcoma has a local 
recurrence rate of 38%, such recurrence being associated with higher 
histological grades5. Oncological outcomes of pelvic osteosarcoma, 
chondrosarcoma and sacral chordoma can therefore be improved4,6,7. 
Computer navigated surgery was introduced to improve the precision of bone 
resection and achieve clear margins whilst minimising the loss of disease-free 
tissue8. Salvage of disease-free tissue favours reconstruction, limb salvage and 
preserves patient function9,10.  
We have previously reported our initial experience with computer navigated 
resection of pelvic and sacral tumours. The technique was safe and effective in 
reducing intralesional resections (8.7%) compared to non-navigated resections 
(27%)11. We also noted reduced blood loss, surgical time and universally clear 
bone resection margins. A number of studies have since published comparable 
results using navigation for these tumours12-17. Despite this increasing body of 
evidence, it is unclear what the local recurrence rate with longer-term follow-up 
will be. Therefore, we lack evidence to support any benefit of navigation over 
traditional surgical techniques when managing these difficult tumours.  This is 
important, as navigation does not guide soft tissue resection, where margins are 
most commonly compromised during surgery18,19.  Compromised resection 
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margins are a poor independent prognostic factor for most histological tumour 
types20.
In 2012 the senior authors published data on 539 patients with primary pelvic 
bone tumours treated at the same institution without navigation. The 10 year 
mortality rate was 31% 1. Rates of wide surgical margins were lower in pelvic 
compared to extremity tumours, with a local recurrence rate of 27%1.  
Aim 
We investigated the outcomes at extended follow-up in 23 patients who had 
undergone computer navigated surgical resections for primary pelvic and sacral 
tumours. The primary outcome of interest was the rate of local disease 
recurrence. Secondary outcomes included the rates of further surgery and all-
cause mortality.  
Patients and Methods 
This was a study of patients who underwent computer navigated limb salvage 
surgery for primary tumours of the pelvis or sacrum at a single specialist 
musculoskeletal oncology centre between April 2010 and 2012. Navigation was 
deemed appropriate in these patients because of the complex anatomy of the 
tumour and/or the perceived difficulty of achieving an adequate resection 
margin and accurate positioning of the implant using standard surgical methods. 
Patients who required hindquarter amputation or an uncomplicated distal 
sacrectomy underwent surgery without the use of navigation.
CT and MRI images were fused by an oncology-specific navigation system 
(Stryker Orthomap 3D Navigation System II; Stryker, Kalamazoo, Michigan). 
These fused images provided an accurate pre-operative three-dimensional (3D) 
model of the tumour, which was correlated with the patient’s anatomy at the 
time of surgery. The surgeon was then able to use these images to plan the plane 
of the surgical resection margins in the workstation before undertaking the 
procedure. Navigated surgery enabled sacral nerve root preservation (n=10), 
limb salvage (n=4) and also permitted reconstruction rather than a hanging hip 
(n=2). Table 1 reports individual patient and tumour characteristics. 
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1 56M Chondrosarcoma P2 7 Excision + EPR**
2 34F Osteosarcoma P1+P4 3 Excision + fibular strut graft
3 40F Chondrosarcoma P2 16 Excision + EPR
4 69M Chondrosarcoma P1+P4 14 Excision alone
5 64M Chondrosarcoma P1+P2+P3 8.5 Excision + EPR
6 60M Chondrosarcoma P2+P3 8 Excision + EPR
7 73M Chondrosarcoma P2+P3 7.5 Excision + EPR
8 73F Chordoma Sacrum 8 Excision alone
9 22F Osteosarcoma P1+P4 11 Excision alone
10 45M Osteosarcoma P1+P2 6 Excision + ‘ice-cream’ cone
11 65F Chordoma Sacrum 7 Excision alone
12 73M Chordoma Sacrum 12.5 Excision alone
13 63M Chordoma Sacrum 11.5 Excision alone
14 26M Ewing’s sarcoma P1+P2+P3 13 Excision alone
15 41M Chondrosarcoma P2+P3 7 Excision + EPR
16 48F Chondrosarcoma P2 5 Excision + EPR
17 21M Chondrosarcoma P1+P2+P3 20
Excision, irradiation and 
reimplantation of hemi 
pelvis + tricortical bone 
graft
18 70F Chordoma Sacrum 12.5 Excision alone




Ewing’s sarcoma P1+P2 8
Excision alone
21 77M Chordoma Sacrum 10 Excision alone
22 58M Chondrosarcoma P1+P2+P3+P4 13 Excision + EPR
23 14F Ewing’s sarcoma Sacrum 4 Excision alone
Abbreviations
M = male; F = female; EPR = endoprosthetic replacement 
* Location of tumour and subsequent resection required classified according to 
Enneking et al. 21: P1 = iliac bone; P2 = periacetabular region; P3 = superior and 
inferior pubic rami; P4 = hemisacrum.
** All endoprosthetic replacements used were custom-made implants
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Information regarding patient selection, pre-operative planning, operative 
technique and post-operative regimen has previously been described11.  The 
registration error was <1mm in all cases.  All margins were planned on the 
navigation cases to be clear of tumour and provide an adequate margin to reduce 
the risk of local recurrence without compromising vial structures through the 
resection. The margins were planned to take into consideration the histological 
tumour type, the grade and location of the tumour.  Resection margins were 
considered adequate if greater than 2mm for osteosarcoma and other subtypes, 
with 4mm specifically  considered adequate for high grade chondrosarcoma22,23. 
Adjunctive therapy use varied by histological subtype. Patients with Ewing’s 
sarcoma and osteosarcoma routinely had neo-adjunctive chemotherapy as per 
international guidelines24,25. A single patient with high-grade chondrosarcoma 
had adjunctive chemotherapy to chest metastasis. 
All patients were reviewed in clinic at three monthly intervals for the first two 
years and at six monthly intervals thereafter as per national guidelines26 27. At 
each visit patients were examined to assess for any clinical signs of local 
recurrence with radiographs of the pelvis (antero-posterior view plus lateral of 
any implants) and chest performed. MRI scans were also performed at six 
monthly intervals to assess for local recurrence and interval changes. Local 
recurrence was defined as any detectable local disease at follow-up, occurring 
either alone or in conjunction with generalised recurrence, in patients who have 
undergone resection. Mortality data was verified using the summative care 
database, which records mortality data for England, Wales and Northern Ireland. 
No patient was specifically recalled for this study with all data collected from 
clinical records and imaging systems as part of routine patient follow-up. 
Institutional review board approval was not required. 
Statistical analysis 
All analyses were performed using SPSS version 21.0 software (IBM Co., Armonk, 
NY).  Local recurrence and mortality rates were calculated using the Kaplan-
Meier method. Time to event, from date of surgery, was established and patients 
censored according to status (alive or dead) or local recurrence. 
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Covariates (patient and surgical) were compared between patients with and 
without local recurrence depending on data distribution. Numerical variables 
with a normal distribution (patient age) were compared using unpaired t-tests. 
To compare medians in non-parametric distributions, we used Mann Witney U-
tests. Categorical data were compared using Fishers’ exact tests.  Due to the small 
size of the cohort and the limited number of outcomes recorded, it was not 
possible to meaningfully investigate the effects of each or multiple covariate(s) 
on local recurrence rates with logistic regression models. The significance level 
for all analyses was p<0.05, with 95% confidence intervals (CIs) also used.
 
Results 
The study comprised 23 patients with primary pelvic or sacral tumours who 
underwent navigated resection.  Nine of the patients were female and mean age 
at presentation was 51 years (10 to 77years, SD 21.1). Median follow-up of 
patients was 6 years (IQR 5.16 to 6.3years) with minimum follow-up of 4 years.  
The median tumour size at presentation was 8cm (IQR 7 to 12.5). Histological 
tumour subtypes were: intermediate or low-grade chondrosarcoma n=8; sacral 
chordoma n=6; high-grade chondrosarcoma n=3, Ewing’s sarcoma n=3; high-
grade osteosarcoma n=2 and low-grade osteosarcoma n=1. 
Clear bone resection margins were achieved in all cases. Margins were 
compromised in two cases, thus 8.7% of the primary tumours had an 
intralesional resection. Both of the patients suffered a local recurrence (Table 2). 
Local recurrence
During the study period eight patients developed local disease recurrence, Table 
2. The overall cumulative local recurrence rate at 6-years was 35.1% (95% 
CI=19.3-58.1%), refer to Figure 1. 
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8 Sacral Chordoma 1 10 8 18 No  AWD
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22 Chondrosarcoma 5 10 13 7 Lung (10)  DOD
Table 2.  Histopathological resection results and clinical outcomes in patients 
with local recurrence (n=8). Abbreviation: DVT = deep vein thrombosis; NED = 
no evidence of disease; AWD = alive with disease; DOD = died of disease
Tumour recurrence stratified by histological subtype was as follows: 
chondrosarcoma 45% (n=5) and sacral chordoma 50% (n=3).  No recurrence 
was seen in Osteosarcoma or Ewing’s sarcoma patients. Patients who suffered a 
local recurrence were older was higher (mean age 43 vs 65 years, p=0.006; Table 
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3). There were no other tumour or surgical covariates which were significantly 
different between patients with and without local recurrence.
Variable Without LR With LR Significance
Number of patients n= 15 n= 8  
Mean Age (years) 43 (SD 23, 95% CI 31 to 56 65 (SD 6.6, 95% CI 60 to 71) 0.006
TUMOUR GRADE:
Low Grade n= 8 n= 3
Intermediate Grade n=2 n= 3
High Grade n= 5 n= 2 0.296
Median tumour size (cm) 10 (7*) 7.8 (8*) 0.591 
Median bone resection margin (mm) 10 (5*) 9.5 (13*)  0.957
Median soft tissue resection margin (mm) 3 (3*) 1 (6*)  0.190
Proportion inadequate soft tissue margin 33% 60% 0.144
Table 3. Patient and tumour variables in patients with and without local 
recurrence. LR = Local recurrence, * = Interquartile range
Three of the eight patients who suffered a local recurrence have died (mean time 
to death=18months (SD 7.2). Three hindquarter amputations were performed as 
a secondary procedure for local recurrence. Four patients had limb salvage 
excision for recurrent lesions. Non-operative treatment for local recurrence was 
chosen by two patients.  Of eight patients with local recurrence one patient has 
no evidence of disease, the remaining 4 patients are alive with disease. 
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Of the 23 patients included in the study, six patients (26.1%) died at a mean time 
of 2.3 years (1.0 to 3.8 years) from surgery. The cumulative 5-year all-cause 
mortality rate was 26.1% (95% CI = 12.7%-49.1%), refer to Figure 2. In total 12 
patients avoided death or local recurrence at last follow-up.  
Further Surgery and complications 
Table 2 reports secondary surgery for oncological indications, metastasis and the 
current status of the patient. Further surgery performed, in addition to that for 
local recurrence, included hip manipulation under anaesthetic following 
dislocation (n=4); wound debridement following infection (n=3) and local 
metastasis excision (n=2). Two patients suffered a sciatic nerve palsy following 
their original surgery.  A 21-year-old patient with radiation induced high grade 
osteosarcoma of the right iliac wing measuring 11cm underwent a hindquarter 
amputation 14 months after the original excision, following the diagnosis of a 
skip lesion. The patient died of metastatic disease 2.5 years later. 
Discussion
Our initial outcomes following computer navigation assisted surgery were 
encouraging with an intralesional resection rate of 8.7% and local recurrence 
rates of 13% up to one-year after surgery11. This study adds to the evolving 
literature by demonstrating the importance of the soft tissue margin, and not just 
the bone margin, when assessing the risk of local recurrence. The role of the 
margin in local recurrence is an evolving subject and whilst much remains 
unknown, there is evidence that the risk of local recurrence following resection is 
a composite function of histological variant, grade, location and quality of the 
tissue comprising the margin. In an unpublished series of 1077 patients with local 
recurrence, we found that 89% occurred within five years of diagnosis and the 
median time to local recurrence was fifteen months. Thus, we are confident that 
the follow-up (median 6-years) reported has sufficient follow up to debate 
oncological outcomes. 
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Computer navigated surgery improves the precision of bony resections, enabling 
the surgeon to conserve native tissue in favour of limb reconstruction and 
preserve adjacent neurovascular structures9,28-30.  In this series we achieved wide 
bone clearance in all patients with no failure in navigation, but we are 
disappointed with the soft-tissue recurrence rate. The degree of soft tissue 
resection was assessed on a individual case basis and all macroscopically 
compromised soft tissue was removed with the tumour. Rather than planning a 
wider bone margin, our findings make it clear that greater attention must be paid 
to the soft tissue dissection. In fact, it may be that a wider soft tissue margin should 
be considered to allow a narrower bone resection margin. Soft-tissue margins are 
independent prognostic factors for local recurrence and survival, with restricted 
access in the pelvis and no interfacial planes to resect these large tumours, thus 
obtaining clear soft-tissue margins remain a challenge2. Even when using 
navigation, studies report soft-tissue recurrence rates of 20 to 25% at short-term 
follow-up8,12,14,20. 
Since publication of the original series in 2013, the authors have defined minimal 
soft tissue margins when resecting high grade osteosarcoma and high grade 
chondrosarcoma tumours to be 2mm and 4mm respectively22,23. Wide resection 
margins improve local recurrence rates in sacral chordoma patients4. Yang et al, 
2016 obtained a minimal 15mm soft tissue margin when resecting primary sacral 
chordomas (n=26), and reduced local recurrence rates to 7.7% at 38 months15. 
The use of chemoradiotherapy in planned intralesional resections also 
demonstrated benefit19. 
We have demonstrated that navigation can achieve clear margins at the bony 
margin but this should not be at the compromise of the soft tissue margin. Equally, 
whilst we have demonstrated the efficacy of navigation in retaining critical 
structures, particularly nerve roots for sacral resections, we are yet to define the 
acceptable margins in many of these histological subtypes. Whilst navigation 
allows a resection close to the tumour, preserving critical structures, the basic 
principle of resection aimed at minimising the risk of local recurrence must not be 
overlooked, even if this necessitates sacrifice of vital neurological, vascular or 
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visceral structures20. When considering the devastating natural history of these 
tumours, we feel navigation surgery offers limb salvage and can preserve bladder/ 
bowel function and mobility. Preservation of life must be considered the primary 
aim of any treatment for a pelvic sarcoma, although respect to quality of life and 
functional restoration is important to discuss with the patient when considering 
surgical options. However, as surgical margins are a very important predictor of 
outcome, the first goal should always be to achieve adequate margins13. 
The authors have published several papers showing that computer navigated 
surgery in the pelvis has several benefits including reduced blood loss, reduced 
complication rates, reduced intralesional rates at surgery and higher disease free 
survival31,32. This study must be taken in context, as it reports the first 23 patients 
out of over 100 patients that have undergone navigated surgery. Clearly, though a 
technical learning curve was mastered quickly, a more philosophical learning 
curve combined with further evidence about the width of an adequate margin was 
appreciated with time. The authors remain supportive that computer navigation 
reduces positive margins at surgery, and it remains routinely used for pelvic 
sarcoma cases. However, we now strive to achieve more radical soft tissue 
margins when possible.
In 2012 the senior authors published data on 539 patients with primary pelvic 
bone or sacral sarcomas treated at the same institution. The cohort  had a ten-year 
overall mortality of 31%1. At five years the current study had a cumulative 
mortality rate of 27.1%. Cho et al, 2012 reports a three-year survival rate of 
patients with pelvic tumours of 80.0% (95% CI 55.3 to 100)12. Overall survival for 
sacral chordoma treated without navigation is 97%, 71% and 47% at 5, 10 and 15 
years respectively4. Chondrosarcoma and osteosarcoma have poorer survival at 
five years, 72% and 27% respectively33,6. In keeping with evidence our study 
suggests that chordoma tends to recur locally with no patients dying during the 
period observed. In contrast, high grade chondrosarcomas, osteosarcomas and 
Ewing’s sarcoma, with aggressive biology, can lead to patient deaths. 
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This study had limitations. Our hospital is a tertiary sarcoma unit treating bone 
sarcomas for an overall population of 22 million people. We have a stringent 
follow-up protocol and offer satellite clinics, but some complications may have 
been treated locally and unknown to us. However, we are confident in the local 
recurrence and mortality data. To determine the origin of local recurrences we 
relied upon cross sectional imaging, histology reports and senior surgeon clinic 
consultations. We feel this is sensitive enough to dichotomize into soft tissue or 
bone as the site of recurrence and differentiate between skip lesions or adjacent 
metastasis. Subgroup analysis, including the ability to perform regression 
modelling, was limited by the sample size and the relatively small number of 
events.  A limitation of this study is that the histopathology specimens were not 
reassessed retrospectively for this study. Due to the nature of this study and the 
extended follow-up from the initial report we did not feel it was necessary for 
these specimens to be re-reviewed in this manner. However, these specimens 
were prospectively assessed by experienced histopathologists at our 
specialist/tertiary oncology centre, and subsequently considered in detail in our 
weekly multi-disciplinary team meetings (which also include the surgeons and 
radiologists). Therefore, we consider the data presented regarding the 
histopathological specimen analysis is robust for the purposes of this particular 
study. It was not the remit of this study to compare to a matched cohort. However, 
future work could encompass a retrospective case control study of comparable 
tumours between navigation and non-navigation assisted surgery, assessing the 
risk of local recurrence and the functional outcomes of patients. However, given 
the rare and heterogenous nature of the tumours included, it may be difficult to 
build comparable groups which take into consideration the myriad of variables 
that are known to effect local recurrence and patient survival. For the purpose of 
this study we wanted to compare longer term outcomes of the patients included 
in the initial study and felt that comparing this to our own institutions historical 
data relays the same important message.
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Following the positive early experience with computer assisted navigation 
resection of complex pelvic and sacral tumours reducing intralesional resection 
rates, we have now observed that similar local recurrence free survival rates were 
seen in navigated resections compared with our historical non-navigated 
resections. Although further research is needed to explain these observations, it is 
suspected that increasing age, advanced disease and tumour biology are 
important contributory factors. Computer navigation-assisted surgery provides 
clear bone resection margins and precise resection, but local recurrence rates are 
determined by the adequacy of soft tissue margins. We advise against routinely 
compromising the latter to preserve function, and we encourage surgeons to 
preserve life by prioritising clear soft-tissue resection margins. 
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